Skip to main content
Elsevier

Journals in Medicine

The Medicine portfolio strives to advance medicine by delivering superior evidence-based education, reference information and decision support tools to clinicians, trainees, and students. Specialties covered include Anesthesiology, Internal Medicine, Surgery, Radiology & Imaging, Pathology, Orthopedics, Ophthalmology, Infectious Disease, Allergy & Immunology, Pediatrics, Obstetrics & Gynecology, Hematology & Oncology, Plastic Surgery, and many more. The Medicine portfolio includes world-renowned titles such as Gray's Anatomy and Netter Atlas of Human Anatomy, Braunwald's Heart Disease, Goldman-Cecil Medicine, Osborn's Brain, Dermatology (Bolognia), Diagnostic Ultrasound (Rumack), The Harriet Lane Handbook, Fanaroff and Martin's Neonatal-Perinatal Medicine, Ferri's Clinical Advisor, Conn's Current Therapy, and more.

  • Current Advances in Cancer Research

    • ISSN: 0895-9803
    Subscriptions

  • The Lancet (North American Edition)

    • ISSN: 0099-5355
    Subscriptions

  • The Lancet Child & Adolescent Health

    • ISSN: 2352-4642
    The Lancet Child & Adolescent Health is an independent journal with an international perspective, and a strong clinical focus. The journal presents the most influential and innovative practice-changing original research, as well as authoritative reviews and insightful opinion pieces to promote the health of the whole child, from the fetal period through to young adulthood.The Lancet Child & Adolescent Health is dedicated to publishing original research that advocates change in, or illuminates, clinical practice or child health across the disciplines of general paediatrics, adolescent medicine, or child development, and across all paediatric subspecialties including (but not limited to) allergy and immunology, cardiology, critical care, endocrinology, fetal and neonatal medicine, gastroenterology, haematology, hepatology and nutrition, infectious diseases, neurology, oncology, psychiatry, respiratory medicine, and surgery.
    Subscriptions

  • The Lancet HIV

    • ISSN: 2352-3018
    Delivering a holistic view of the pandemic, The Lancet HIV publishes original research, comment, and correspondence that unifies clinical, epidemiological, and operational disciplines across a single vision of health for those living with HIV. The journal is the global leader for essential original research in the field, covering innovative treatments and the biological research underpinning such developments, novel methods of service delivery, and new ways of confronting HIV/AIDS worldwide.
    Subscriptions

  • The Lancet Infectious Diseases

    • ISSN: 1473-3099
    The Lancet Infectious Diseases is an authoritative forum for key opinion leaders across medicine, government, and health systems to influence clinical practice, explore global policy, and inform constructive, positive change worldwide.As the global leader in clinical infectious diseases, The Lancet Infectious Diseases delivers essential original research, expert review, candid commentary, and breaking news to provide context and perspective on today's most important medical advances across the broad spectrum of clinical infectious diseases.
    Subscriptions

  • The Lancet Oncology

    • ISSN: 1470-2045
    The Lancet Oncology is the world-leading clinical oncology journal publishing high-quality, peer reviewed original research (especially reports from clinical trials), reviews, comment and opinion, weekly news, and Commissions (typically in partnership with societies, governments, NGOs, and academy centres). The journal is lively and informative, covering international issues relevant to clinical cancer specialties worldwide. Content covers topics that advance clinical practice, challenge the status quo, advocate change in health policy, and tackle issues related to global oncology.
    Subscriptions

  • The Lancet Rheumatology

    • ISSN: 2665-9913
    The Lancet Rheumatology is an independent journal committed to publishing content relevant to rheumatology specialists worldwide, with a focus on studies that advance clinical practice, challenge the status quo, and advocate change in health policy. The journal publishes clinical research (with a focus on clinical trials), expert reviews, and provocative comment and opinion relating to the diagnosis and classification, management, and prevention of rheumatic diseases, including arthritic, musculoskeletal, and connective tissue diseases, as well as disorders of the immune system. The journal also publishes high-quality human translational studies that are supported by robust clinical data, with priority given to studies that identify potential new therapeutic targets, advance efforts toward precision medicine, or have the potential to directly inform future clinical trials.With a strong clinical focus, The Lancet Rheumatology provides an independent voice for the rheumatology community and advocates strongly for the improved lives of patients with rheumatic diseases around the globe.
    Subscriptions

  • The Lancet Haematology

    • ISSN: 2352-3026
    The Lancet Haematology is an authoritative forum for key opinion leaders across medicine, government, and health systems to influence clinical practice, explore global policy, and inform constructive, positive change worldwide. The journal publishes original research, review, and opinion covering international issues, providing a clear, independent perspective about the clinical advances and practice-changing research shaping clinical haematology.The Lancet Haematology is dedicated to publishing original research that advocates change in, or illuminates, haematological clinical practice, including, but not limited to, the subjects of: haematology-oncology... red and white blood cell disorders, platelet disorders, stem cell transplantation and induced pluripotent stem cells, and transfusion medicine.
    Subscriptions

  • Med

    • ISSN: 2666-6340
    Med is a flagship clinical and translational research monthly journal published by Cell Press, the global publisher of trusted and authoritative science journals including Cell, Chem, and Joule. Our mission is to accelerate translation of bench research to the clinic by providing a communication forum for the exchange of knowledge, fresh ideas, and thought-leadership among translational researchers, clinicians, and Biotech and Pharma scientists as well as other medical research stakeholders. Our goal is to sustainably and ethically improve health globally.Med publishes rigorously vetted original research and state-of-the-art Review and Perspective articles across the translational and clinical continuum. Our translational research articles are deeply rooted in understanding disease mechanisms, with demonstrable functional impact and broad transformative insights. Our clinical studies cover case reports, first-in-human studies, and large-scale clinical trials, including phase IV, which have the potential to change the course of medical research and improve clinical practice.We are interested in research with likely immediate impact on clinical therapy. These include clinical studies, translational research papers addressing disease mechanism and/or therapies, biotechnology and engineering advances with important clinical impact, and resources (such as informational databases) of broad medical utility. Topics of interest for the journal include but are not limited to:Aging and health-span interventions: sarcopenia; senescence and senolytic treatments; dietary interventions; hormonal disordersBiomedical engineering – new device optimization and diagnostic toolsCancer: immuno-oncology; tumor evolution and cancer genetics; surgery and therapeutic modalitiesCardiovasc... and metabolic disease: heart disease; diabetes; obesity; NAFLD/NASHGenetics and cell-based therapies: medical genomics; CRISPR-based; RNAi; stem cells; organoids; transplantationHealt... economics and public policy: global challenges; health access; public health interventions; clinical practicesHuman microbiome: mechanistic studies of the human microbiomes impact on diseaseImmunology: allergy and inflammation; autoimmunity; innate immunity; graft-versus host disease; vaccinologyInfectiou... diseases: HIV/AIDS; SARS; ebola; other bacterial, viral, fungal, or parasitic infections; infectious diseases epidemiology; antimicrobials and resistanceNeurology: Alzheimers disease; dementia; cognitive dysfunctions; brain-vascular dysfunction; Parkinsons and movement disorders; amyotrophic lateral sclerosis; depression; neuroengineering therapiesVisit the Cell Press website for more information about Med - http://www.cell.com/...
    Subscriptions

  • The Lancet Respiratory Medicine

    • ISSN: 2213-2600
    The Lancet Respiratory Medicine is an authoritative forum for key opinion leaders across medicine, government, and health systems to influence clinical practice, explore global policy, and inform constructive, positive change worldwide. The journal is the global leader for essential original research in critical care and respiratory medicine, and delivers expert review, candid commentary, and breaking news, providing a clear, independent perspective about the clinical advances and practice-changing research shaping these fields globally.
    Subscriptions

Related subjects